Cytosorbents (NASDAQ:CTSO) Earns “Buy” Rating from D. Boral Capital
Cytosorbents (NASDAQ:CTSO – Get Free Report)‘s stock had its “buy” rating reaffirmed by D. Boral Capital in a research note issued to investors on Thursday,Benzinga reports. They currently have a $10.00 price target on the medical research company’s stock. Several other analysts have also recently commented on CTSO. HC Wainwright restated a “neutral” rating and […]
Cytosorbents (NASDAQ:CTSO – Get Free Report)‘s stock had its “buy” rating reaffirmed by D. Boral Capital in a research note issued to investors on Thursday,Benzinga reports. They currently have a $10.00 price target on the medical research company’s stock. Several other analysts have also recently commented on CTSO. HC Wainwright restated a “neutral” rating and […]
